Matrix metalloproteinases in asthma and COPD.

[1]  M. Sporn,et al.  Novel inhibitors of matrix metalloproteinase gene expression as potential therapies for arthritis. , 2004, Clinical orthopaedics and related research.

[2]  William C. Parks,et al.  Matrix metalloproteinases as modulators of inflammation and innate immunity , 2004, Nature Reviews Immunology.

[3]  L. Boulet,et al.  Metalloproteinase-9 in Induced Sputum Correlates with the Severity of the Late Allergen-Induced Asthmatic Response , 2004, Respiration.

[4]  J. Foidart,et al.  Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases mRNA transcripts in the bronchial secretions of asthmatics , 2004, Laboratory Investigation.

[5]  R. Sansores,et al.  Matrix metalloproteinases activity in COPD associated with wood smoke. , 2004, Chest.

[6]  V. Lagente,et al.  Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease , 2004, Inflammation Research.

[7]  S. Wenzel,et al.  Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids. , 2003, The Journal of allergy and clinical immunology.

[8]  Y. Oh,et al.  Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow. , 2003, Journal of Korean medical science.

[9]  T. Koga,et al.  Increased circulating 92 kDa matrix metalloproteinase (MMP-9) activity in exacerbations of asthma , 2003, Thorax.

[10]  R. Pauwels,et al.  Matrix Metalloproteinase-9-Mediated Dendritic Cell Recruitment into the Airways Is a Critical Step in a Mouse Model of Asthma1 , 2003, The Journal of Immunology.

[11]  R. Buhl,et al.  Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. , 2003, Respiratory medicine.

[12]  S. Wenzel,et al.  Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair. , 2003, The Journal of allergy and clinical immunology.

[13]  R. Visse,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[14]  Z. Han,et al.  Expression of matrix metalloproteinases MMP-9 within the airways in asthma. , 2003, Respiratory medicine.

[15]  N. Jarjour,et al.  Role of matrix metalloproteinases in asthma , 2003, Current opinion in pulmonary medicine.

[16]  D. Nahm,et al.  Metalloproteinase‐9 is increased after toluene diisocyanate exposure in the induced sputum from patients with toluene diisocyanate‐induced asthma , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[17]  Richard J Martin,et al.  Increased matrix metalloproteinase-9 with elastolysis in nocturnal asthma. , 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[18]  K. Chung,et al.  Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. , 2002, Chest.

[19]  J. Foidart,et al.  Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. , 2002, Chest.

[20]  P. Barnes,et al.  Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory cell and molecular biology.

[21]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[22]  N. Anthonisen,et al.  The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. , 2002, Human molecular genetics.

[23]  V. Lagente,et al.  Increased release of matrix metalloproteinase‐9 in the plasma of acute severe asthmatic patients , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[24]  Hidetoshi Nakamura,et al.  Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema. , 2001, Biochemical and biophysical research communications.

[25]  Y. Rhee,et al.  The involvement of matrix metalloproteinase‐9 in airway inflammation of patients with acute asthma , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[26]  J. D’Armiento,et al.  Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. , 2001, American journal of respiratory and critical care medicine.

[27]  Z. Werb,et al.  How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.

[28]  J. Foidart,et al.  MMP-2- and MMP-9-Linked Gelatinolytic Activity in the Sputum from Patients with Asthma and Chronic Obstructive Pulmonary Disease , 2000, International Archives of Allergy and Immunology.

[29]  W. Busse,et al.  Increased matrix metalloproteinase-9 in the airway after allergen challenge. , 2000, American journal of respiratory and critical care medicine.

[30]  M. Gaxiola,et al.  Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. , 2000, Chest.

[31]  D. Hartmann,et al.  Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus. , 1999, American journal of respiratory and critical care medicine.

[32]  T. Betsuyaku,et al.  Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. , 1999, American journal of respiratory and critical care medicine.

[33]  L. O’Driscoll,et al.  Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. , 1997, American journal of respiratory and critical care medicine.

[34]  C. O'connor,et al.  Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. , 1997, Thorax.